-Reuters Citing State Department Official
SciSparc Signs Agreement For The Supply Of CBD-Rich Cannabis Oil For Its Clinical Trial On Children With Autism Spectrum Disorder
The cannabis oil will be used as a part of the Company's proprietary SCI-210 treatment combination of CBD and CannAmide™